relation to short-term loan, accrued as at the Closing Date. In this connection, the Board of Directors’ Meeting deemed it appropriate to propose the Shareholders’ Meeting to consider authorizing the Chief
loan, accrued as at the Closing Date. In this connection, the Board of Directors’ Meeting deemed it appropriate to propose the Shareholders’ Meeting to consider authorizing the Chief Executive Officer or
the January 2019. In this regard, the Board of Directors has authorized the executive committee or the Chief Executive Officer or the person entrusted by executive committee or the Chief Executive
0.002 times, and its debt to equity ratio was 0.04 times. Please be informed accordingly. Very truly yours, Supamas Isarabhakdi Chief Executive Officer บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต
Consulting fees for the audit of the business condition and legal aspects of the subsidiary investment in the amount of Baht 2.25 million. 9.3 In the year 2018, there was a reversal doubtful debt by Baht 7.69
2016 30 JUNE 2017 Not yet due 134 116 Up to 3 months 47 651 3 - 6 months - 1 6 - 12 months - 1 Over 12 months 14 11 Total 195 194 Allowance for doubtful debt 14 11 1 Trade receivables aged up to 3 months
debt 14 11 LIABILITIES AND SHAREHOLDERS’ EQUITY LIABILITIES AND EQUITY BREAKDOWN 31 DECEMBER 2016 30 SEPTEMBER 2017 (THB mn) % out of total liabilities and equity (THB mn) % out of total liabilities and
months 145 160 3 - 6 months 67 30 6 - 12 months 13 27 Over 12 months 11 11 Total 509 455 Allowance for doubtful debt 6 7 LIABILITIES AND SHAREHOLDERS’ EQUITY LIABILITIES AND EQUITY BREAKDOWN 31 DECEMBER
liabilities of the Group were decreased from Advance received from construction contracts and construction income received in advance. Due to revenue recognized during this period. o Debt to Equity ratio (D/E